Source:http://linkedlifedata.com/resource/pubmed/id/20011872
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2009-12-17
|
| pubmed:abstractText |
There is strong evidence that methylene blue (MB), an inhibitor of guanylate cyclase, is an excellent therapeutic option for vasoplegic syndrome (VS) treatment in heart surgery. The aim of this article is to review the MB's therapeutic function in the vasoplegic syndrome treatment.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
1678-9741
|
| pubmed:author |
pubmed-author:Alves JuniorLafaieteL,
pubmed-author:BassettoSolangeS,
pubmed-author:EvoraPatrícia MartinezPM,
pubmed-author:EvoraPaulo Roberto BarbosaPR,
pubmed-author:MenardiAntonio CarlosAC,
pubmed-author:ReisCelso Luís dosCL,
pubmed-author:RibeiroPaulo José de FreitasPJ,
pubmed-author:RodriguesAlfredo JoséAJ,
pubmed-author:VicenteWalter Vilella de AndradeWV
|
| pubmed:issnType |
Electronic
|
| pubmed:volume |
24
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
279-88
|
| pubmed:meshHeading | |
| pubmed:year |
2009
|
| pubmed:articleTitle |
Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties.
|
| pubmed:affiliation |
Head of the Surgery and Anatomy Department, Ribeirão Preto Medical School - USP, Brazil. prbevora@fmrp.usp.br
|
| pubmed:publicationType |
Journal Article,
Review
|